CL2015000688A1 - Metodo o proceso para convertir un deshidrato de un depsipeptido macrociclico y/o su analogo de hemiaminal en el compuesto macrociclico y compuestos intermediarios. - Google Patents

Metodo o proceso para convertir un deshidrato de un depsipeptido macrociclico y/o su analogo de hemiaminal en el compuesto macrociclico y compuestos intermediarios.

Info

Publication number
CL2015000688A1
CL2015000688A1 CL2015000688A CL2015000688A CL2015000688A1 CL 2015000688 A1 CL2015000688 A1 CL 2015000688A1 CL 2015000688 A CL2015000688 A CL 2015000688A CL 2015000688 A CL2015000688 A CL 2015000688A CL 2015000688 A1 CL2015000688 A1 CL 2015000688A1
Authority
CL
Chile
Prior art keywords
macrocyclic
hemiaminal
dehydrate
intermediates
analog
Prior art date
Application number
CL2015000688A
Other languages
English (en)
Inventor
Murat Acemoglu
Heribert Hellstern
Felix Kollmer
John Lopez
Robert Schreiber
Christian Sprecher
Hans Stettler
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=46317455&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CL2015000688(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of CL2015000688A1 publication Critical patent/CL2015000688A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K1/00General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/06General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length using protecting groups or activating agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K11/00Depsipeptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K11/02Depsipeptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof cyclic, e.g. valinomycins ; Derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K11/00Depsipeptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04Linear peptides containing only normal peptide links
    • C07K7/06Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Cookers (AREA)
  • Cereal-Derived Products (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
CL2015000688A 2011-04-20 2015-03-18 Metodo o proceso para convertir un deshidrato de un depsipeptido macrociclico y/o su analogo de hemiaminal en el compuesto macrociclico y compuestos intermediarios. CL2015000688A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201161477319P 2011-04-20 2011-04-20

Publications (1)

Publication Number Publication Date
CL2015000688A1 true CL2015000688A1 (es) 2015-06-05

Family

ID=46317455

Family Applications (2)

Application Number Title Priority Date Filing Date
CL2013003037A CL2013003037A1 (es) 2011-04-20 2013-10-18 Proceso de preparacion de un depsipeptido ciclico que considera desproteger un grupo oh, oxidarlo, ciclarlo y finalmente desproteger selectivamente algunos grupos; y compuestos intermediarios.
CL2015000688A CL2015000688A1 (es) 2011-04-20 2015-03-18 Metodo o proceso para convertir un deshidrato de un depsipeptido macrociclico y/o su analogo de hemiaminal en el compuesto macrociclico y compuestos intermediarios.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
CL2013003037A CL2013003037A1 (es) 2011-04-20 2013-10-18 Proceso de preparacion de un depsipeptido ciclico que considera desproteger un grupo oh, oxidarlo, ciclarlo y finalmente desproteger selectivamente algunos grupos; y compuestos intermediarios.

Country Status (22)

Country Link
US (2) US8614289B2 (es)
EP (1) EP2699585A1 (es)
JP (2) JP5951006B2 (es)
KR (1) KR101580729B1 (es)
CN (2) CN104804072A (es)
AR (1) AR086168A1 (es)
AU (1) AU2012245980B2 (es)
BR (1) BR112013026660A2 (es)
CA (1) CA2833109A1 (es)
CL (2) CL2013003037A1 (es)
CO (1) CO6801799A2 (es)
EA (2) EA025546B1 (es)
GT (1) GT201300256A (es)
IL (1) IL228727A0 (es)
MA (1) MA35034B1 (es)
MX (1) MX337526B (es)
PE (1) PE20141206A1 (es)
PH (1) PH12013502101A1 (es)
SG (1) SG193918A1 (es)
TN (1) TN2013000385A1 (es)
TW (1) TW201249863A (es)
WO (1) WO2012143888A1 (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY151973A (en) 2007-08-17 2014-07-31 Novartis Ag Cyclic depsipeptides
US8680054B2 (en) 2011-04-20 2014-03-25 Novartis Ag Suspension type topical formulations comprising cyclic depsipeptide
US8614289B2 (en) 2011-04-20 2013-12-24 Novartis Ag Processes for the manufacture of macrocyclic depsipeptides and new intermediates
US8987413B2 (en) 2012-10-09 2015-03-24 Novartis Ag Aldehyde acetal based processes for the manufacture of macrocyclic depsipeptides and new intermediates
US9067978B2 (en) 2012-10-09 2015-06-30 Novartis Ag Solution phase processes for the manufacture of macrocyclic depsipeptides and new intermediates
CN106029684A (zh) 2014-04-08 2016-10-12 诺华股份有限公司 用于生产大环缩酚酸肽和新中间体的新型缩醛类方法
LT3298027T (lt) * 2015-05-20 2021-08-10 Boehringer Ingelheim Animal Health USA Inc. Antihelmintiniai depsipeptido junginiai
JP2018530543A (ja) 2015-09-17 2018-10-18 マサチューセッツ インスティテュート オブ テクノロジー 固相ペプチド合成のための方法およびシステム
KR102031186B1 (ko) * 2017-01-11 2019-11-08 주식회사 엘지생활건강 단백질 강도 강화용 조성물
US11643438B2 (en) 2018-07-20 2023-05-09 The Board Of Regents Of The University Of Oklahoma Antimicrobial peptides and methods of use

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3043252C2 (de) 1980-11-15 1982-12-02 Degussa Ag, 6000 Frankfurt Cyclische Acetale von N-Acylglutaminsäure -γ- semialdehyden, Verfahren zu deren Herstellung und ihre Verwendung
US5595756A (en) 1993-12-22 1997-01-21 Inex Pharmaceuticals Corporation Liposomal compositions for enhanced retention of bioactive agents
DE4421113A1 (de) 1994-06-16 1995-12-21 Biotechnolog Forschung Gmbh Chondramide, Gewinnungsverfahren, Mittel mit Chondramiden und Mischkultur zur Chondramid-Gewinnung
DE19828043A1 (de) 1998-06-24 1999-12-30 Bayer Ag Ektoparasitizide Mittel
JP2000154198A (ja) 1998-11-20 2000-06-06 Nisshin Flour Milling Co Ltd 環状デプシペプチドの固相合成方法及びその中間体
GB0108234D0 (en) * 2001-04-02 2001-05-23 Pharma Mar Sa Process for producing trunkamide A compounds
US20040110228A1 (en) 2002-04-01 2004-06-10 Mcalpine Shelli R. Combinatorial organic synthesis of unique biologically active compounds
KR101205257B1 (ko) 2003-06-06 2012-11-27 아렉시스 악티에볼라그 피부 상태 또는 암 치료를 위한 scce 저해제로서의 융합된 헤테로사이클 화합물의 용도
GB0322140D0 (en) 2003-09-22 2003-10-22 Pfizer Ltd Combinations
EP1716248A1 (en) 2004-02-03 2006-11-02 Bayer HealthCare AG Diagnostics and therapeutics for diseases associated with kallikrein 7 (klk7)
CA2651796A1 (en) 2006-02-27 2007-09-07 Arizona Board Of Regents For And On Behalf Of Arizona State University Identification and use of novopeptides for the treatment of cancer
GB0715750D0 (en) 2007-08-13 2007-09-19 Karus Therapeutics Ltd Chemical compounds
WO2009024528A1 (en) 2007-08-17 2009-02-26 Novartis Ag Use of cyclic depsipeptides to inhibit kallikrein 7
MY151973A (en) 2007-08-17 2014-07-31 Novartis Ag Cyclic depsipeptides
DE102007052391A1 (de) 2007-10-31 2009-05-07 Henkel Ag & Co. Kgaa Mattwachs
US20110112121A1 (en) 2009-07-06 2011-05-12 Joerg Berghausen Pharmaceutical Compositions and Solid Forms
KR101004362B1 (ko) 2010-03-19 2010-12-28 가톨릭대학교 산학협력단 자가 면역 질환 예방 및 치료용 TNF-α와 TWEAK 이중 길항제
US20120064136A1 (en) 2010-09-10 2012-03-15 Nanobio Corporation Anti-aging and wrinkle treatment methods using nanoemulsion compositions
WO2012035468A2 (en) 2010-09-14 2012-03-22 Trima - Israel Pharmaceutical Products Maabarot Ltd. Foamable topical composition
KR20140005998A (ko) 2011-01-24 2014-01-15 안테리오스, 인코퍼레이티드 나노입자 조성물, 이의 제형, 및 그의 용도
EP2667854B1 (en) 2011-01-24 2019-01-16 Anterios, Inc. Nanoparticle compositions
US8614289B2 (en) 2011-04-20 2013-12-24 Novartis Ag Processes for the manufacture of macrocyclic depsipeptides and new intermediates
US8680054B2 (en) 2011-04-20 2014-03-25 Novartis Ag Suspension type topical formulations comprising cyclic depsipeptide
US9067978B2 (en) 2012-10-09 2015-06-30 Novartis Ag Solution phase processes for the manufacture of macrocyclic depsipeptides and new intermediates
US8987413B2 (en) 2012-10-09 2015-03-24 Novartis Ag Aldehyde acetal based processes for the manufacture of macrocyclic depsipeptides and new intermediates
CN106029684A (zh) 2014-04-08 2016-10-12 诺华股份有限公司 用于生产大环缩酚酸肽和新中间体的新型缩醛类方法

Also Published As

Publication number Publication date
IL228727A0 (en) 2013-12-31
JP5951006B2 (ja) 2016-07-13
US8614289B2 (en) 2013-12-24
CN103476789A (zh) 2013-12-25
EA025546B1 (ru) 2017-01-30
TN2013000385A1 (en) 2015-01-20
PH12013502101A1 (en) 2017-10-25
AR086168A1 (es) 2013-11-27
CN103476789B (zh) 2016-11-09
MA35034B1 (fr) 2014-04-03
WO2012143888A1 (en) 2012-10-26
US20120277406A1 (en) 2012-11-01
AU2012245980A1 (en) 2013-10-03
JP2014511899A (ja) 2014-05-19
KR20130140204A (ko) 2013-12-23
EA201500734A1 (ru) 2015-11-30
GT201300256A (es) 2015-02-19
SG193918A1 (en) 2013-11-29
EA201391554A1 (ru) 2014-11-28
CL2013003037A1 (es) 2014-10-03
AU2012245980B2 (en) 2015-01-29
JP2016164158A (ja) 2016-09-08
US20140080995A1 (en) 2014-03-20
BR112013026660A2 (pt) 2016-09-06
MX2013012188A (es) 2013-11-04
CO6801799A2 (es) 2013-11-29
EP2699585A1 (en) 2014-02-26
US9278997B2 (en) 2016-03-08
CA2833109A1 (en) 2012-10-26
PE20141206A1 (es) 2014-09-28
TW201249863A (en) 2012-12-16
KR101580729B1 (ko) 2015-12-28
MX337526B (es) 2016-03-09
CN104804072A (zh) 2015-07-29

Similar Documents

Publication Publication Date Title
CL2015000688A1 (es) Metodo o proceso para convertir un deshidrato de un depsipeptido macrociclico y/o su analogo de hemiaminal en el compuesto macrociclico y compuestos intermediarios.
PL2798311T3 (pl) Enkoder absolutny wysokiej rozdzielczości
DK2721821T3 (da) Paralleliseringsvenlige fusionskandidater til videokodning
PT2824865T (pt) Espaço de busca para r-pdcch não entrelaçado
HUE036181T2 (hu) Sertésekbõl izolált bakteriális törzsek
DK2391863T3 (da) Multimodalt førerløst luftfartøj
EP2844781A4 (en) METHOD FOR DEPOSITION OF ORGANIC MATTER
CL2014003318A1 (es) Un método para el fraccionamiento de lignina: fraccion de lignina.
PL2718024T3 (pl) Instalacja lakiernicza
BR112013030907A2 (pt) anel de pistão e respectivos revestimento resistente ao desgaste e método de aplicação.
EP2682463A4 (en) BACTERIOZIN OBTAINED FROM LACTOBACILLUS RHAMNOSUS
BR112013019695A2 (pt) material compósito de mancal de deslizamento
TWI561288B (en) Novel method for purifying organic solid materials
PL2797929T3 (pl) Nowy analog rapamycyny
ZA201108596B (en) Bearing retainer assembly
DK2534070T3 (da) Slidsgriber
EP2647859A4 (en) SEGMENTED RETAINING MEMBER FOR BEARING BEARING
CO7061067A2 (es) Métodos para el tratamiento de un impedimento sensorial-motriz relacionado con el accidente cerebrovascular con el uso de aminopiridinas
BR112013010326A2 (pt) corpos de válvula tendo capacidade de redução de impulso integral
EP2678788A4 (en) INCREASE RESEARCH RESULTS
EP2753582A4 (en) PRESSURE RETURN OF AN ORGANIC MATERIAL
CR20130362A (es) Método para el control de hongos fitopatógenos
PL391879A1 (pl) Sposób oczyszczania 1,2-dichloropropanu
BR112012028716A2 (pt) método para a extração de material de uma fruta da família sapindacea
IT1399702B1 (it) Metodo e gruppo per la rullatura di uno pneumatico